Muhammad Umair Mushtaq/X
Jun 15, 2025, 09:17
Muhammad Umair Mushtaq: Excited to Share that I’ve Been Selected as a Next Generation Scholar for the National Cancer Institute’s Blood and Marrow Transplant Clinical Trials Network
Muhammad Umair Mushtaq, Associate Professor Hematologic Malignancies & Cellular Therapeutics at KU Medical Center, shared a post on X:
“Excited to share that I’ve been selected as a Next Generation Scholar for the National Cancer Institute’s Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 2025-2026! Grateful for the opportunity and honored to contribute to this groundbreaking work in advancing cancer therapies.”
Stay updated with Hemostasis Today.
-
Nov 15, 2025, 12:24Thomas Reiser: Can AI Keep Up with Thrombosis Specialists?
-
Nov 15, 2025, 12:13Michael Makris on Immediate Suspension of Use of Plasma Derived FIX Concentrates in Punjab
-
Nov 15, 2025, 09:32Tushar Pandey: Hounoured to Be Part of Hematocon 2025
-
Nov 15, 2025, 09:11Lisa Murphy invites You to Join Her at Stroke Foundation’s Run4Stroke Marathon
-
Nov 15, 2025, 08:56Ahmed Bennis on Potential Use of P2Y12 Inhibitors as Safer Alternative in Monotherapy
-
Nov 15, 2025, 08:39Marika Nöjd: Donating Blood is An Easy Way to Do Good!
-
Nov 15, 2025, 08:19Joseph Caprini Released His UIP 2025 Session on VTE Recurrence Risk
-
Nov 15, 2025, 07:14Paul Bolaji Invites You to ”Thrombolytic Therapy in Acute Stroke in African Patients” Seminar
-
Nov 15, 2025, 07:03Carla Goulart Peron Explores The Role of Technology and Collaboration in Global Stroke Action
